This prospective, multicenter, single-arm observational study aims to document the clinical performance and safety of a sterile, bacteria-binding, super-absorbent wound dressing for the intended use in a daily clinical practice. 50 patients (male/female) with superficial wounds of any etiology affecting only epidermis and dermis layer, with one or more clinical signs of infection or at high risk of infection and also high to very high exudate levels will be observed over a period of 14 days.
Study Type
OBSERVATIONAL
Enrollment
32
Welsh Wound Innovation Centre
Ynysmaerdy, Rhondda Cynon Taf, United Kingdom
Number of patients with persisting infections will be documented in a standardized Case Report Form (CRF).
Symptoms such as odor, pain, localized heat and erythema will be assessed by a clinician and documented in four different categories depending on its severity.
Time frame: 14 days
Number of participants with newly developed infections will be documented in a standardized Case Report Form (CRF)
Symptoms such as odor, pain, localized heat and erythema will be assessed by a clinician and documented in four different categories depending on its severity.
Time frame: 14 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.